Sarcopenia: definition and diagnosing of a new disease
Interní klinika 1. LF UK a ÚVN – Vojenská fakultní nemocnice Praha
Clinical Osteology 2019; 24(1): 14-18
Sarcopenia is a progressive and generalized impairment of skeletal muscles (muscle failure) associated with an increased risk of harmful incidents such as falls, fractures, physical disability and increased mortality. After 8 years of intensive research the EWGSOP (European Working Group on Sarcopenia in Older People) issued new and revised recommendations for definition and diagnosis of this condition. This recommendation includes an algorithm for screening of sarcopenia, defines methods suitable for examination of muscle quality/quantity, muscle strength and physical performance. For the first time, the cut-off points used to determine the diagnosis were consensually presented. Sarcopenia is now defined as a disease with its own assigned diagnostic code.
ageing – EWGSOP2 – muscle strength – muscle strength – sarcopenia
- Rosenberg IH. Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19–21, 1988. Am J Clin Nutr 1989; 50(Suppl 5): 1231–1233. Dostupné z DOI: <https://doi.org/10.1093/ajcn/50.5.1231>.
- Cruz-Jentoft AJ, Bahat G, Bauer J et al. [European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2]. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48(1): 16–31. Dostupné z DOI: <http://dx.doi.org/10.1093/ageing/afy169>.
- Vellas B, Fielding RA, Bens C et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging 2018; 7(1): 2–9. Dostupné z DOI: <http://dx.doi.org/10.14283/jfa.2017.30>.
- Antunes AC, Araujo DA, Verissimo MT et al. Sarcopenia and hospitalisation costs in older adults: a cross-sectional study. Nutr Diet 2017; 74(1): 46–50. Dostupné z DOI: <http://dx.doi.org/10.1111/1747–0080.12287>.
- Steffl M, Sima J, Shiells K et al. The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health. Ageing and Retirement in Europe (SHARE). Clin Interv Aging 2017; 12: 2003–2007. Dostupné z DOI: <http://dx.doi.org/10.2147/CIA.S150826>.
- Malmstrom TK, Miller DK, Simonsick EM et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016; 7(1): 28–36. Dostupné z DOI: <http://dx.doi.org/10.1002/jcsm.12048>.
- Fichtl C, Kužma M, Jackuliak P et al. Examination methods in sarcopenia. Clin Osteol 2018, 23(3), 105–111.
- Beaudart C, Biver E, Reginster JY et al. Validation of the SarQoL(R), a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle 2017; 8(2): 238–244. Dostupné z DOI: <http://dx.doi.org/10.1002/jcsm.12149>.
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010, 39(4): 412–423. Dostupné z DOI: <http://dx.doi.org/10.1093/ageing/afq034>.
- Morley JE, Vellas B, van Kan GA et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14(6): 392–397. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jamda.2013.03.022>.
Gynaecology and obstetrics
General practitioner for adults